Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis

Clinical Rheumatology

Volumn 29, Issue 3, 2010, Pages 241-246

  Louthrenoo, Worawit ^a   Kasitanon, Nuntana ^a   Wichainun, Ramjai ^a   Wangkaew, Suparaporn ^a   Sukitawut, Waraporn ^a   Kuwata, Shoji ^b   Takeuchi, Fujio ^c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti agalactosyl IgG antibodies; Anti cyclic citrullinated peptide antibodies; Rheumatoid arthritis; Rheumatoid factor; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

AGALACTOSYL ANTIBODY; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; AGALACTOSYL IGG; ANTIIDIOTYPIC ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THAILAND; ANTIBODY SPECIFICITY; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SCLERODERMA, SYSTEMIC; SEROEPIDEMIOLOGIC STUDIES; THAILAND; YOUNG ADULT;

EID: 77950614799     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1284-y     Document Type: Article

References (32)

1. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
2. Tighe H, Carson DA (2005) Rheumatoid factor. In: Harris ED, Budd RC, Firestein GS et al (eds) Kelley's textbook of rheumatology. Philadelphia, Elsevier Saunders, pp 301-310
3. S Bas S Genevay O Meyer C Gabay 2003 Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis Rheumatology (Oxford) 42 677 680 10.1093/rheumatology/ keg184 1:CAS:528:DC%2BD3sXjtlGmsrk%3D (Pubitemid 37220878)
4. J Avouac L Gossec M Dougados 2006 Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review Ann Rheum Dis 65 845 851 10.1136/ard.2006.051391 1:CAS:528:DC%2BD28XntF2mu7Y%3D 16606649
5. T Matsui K Shimada N Ozawa H Hayakawa F Hagiwara H Nakayama, et al. 2006 Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis J Rheumatol 33 2390 2397 1:CAS:528: DC%2BD2sXhtVCntbs%3D 16924694
6. EJ Kroot BA de Jong MA van Leeuwen H Swinkels FH van den Hoogen M van't Hof, et al. 2000 The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 43 1831 1835 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 1:CAS:528:DC%2BD3cXmtFKju7w%3D 10943873 (Pubitemid 30640938)
7. LM Jansen D van Schaardenburg I van der Horst-Bruinsma RJ van der Stadt MH de Koning BA Dijkmans 2003 The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis J Rheumatol 30 1691 1695 1:CAS:528:DC%2BD3sXntVyitbg%3D 12913923 (Pubitemid 36962444)
8. K Forslind M Ahlmen K Eberhardt I Hafstrom B Svensson 2004 Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis 63 1090 1095 10.1136/ard.2003.014233 1:CAS:528:DC%2BD2cXnvFWkt7k%3D 15308518 (Pubitemid 39120360)
9. SW Syversen PI Gaarder GL Goll S Odegard EA Haavardsholm P Mowinckel, et al. 2008 High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study Ann Rheum Dis 67 212 217 10.1136/ard.2006.068247 1:STN:280:DC%2BD1c%2FisVygug%3D%3D 17526555 (Pubitemid 351183310)
10. RB Parekh RA Dwek BJ Sutton DL Fernandes A Leung D Stanworth, et al. 1985 Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG Nature 316 452 457 10.1038/316452a0 1:CAS:528:DyaL2MXltVehurY%3D 3927174 (Pubitemid 16238456)
11. M Watson PM Rudd M Bland RA Dwek JS Axford 1995 Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides Arthritis Rheum 42 1682 1690 10.1002/1529-0131(199908)42: 8<1682::AID-ANR17>3.0.CO;2-X (Pubitemid 30263637)
12. Y Imafuku H Yoshida Y Yamada 2003 Reactivity of agalactosyl IgG with rheumatoid factor Clin Chim Acta 334 217 223 10.1016/S0009-8981(03)00245-6 1:CAS:528:DC%2BD3sXlsVWqtbY%3D 12867295 (Pubitemid 36836078)
13. A Matsumoto K Shikata F Takeuchi N Kojima T Mizuochi 2000 Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation J Biochem 128 621 628 1:CAS:528: DC%2BD3cXosFOjsrc%3D 11011144
14. H Das T Atsumi Y Fukushima H Shibuya K Ito Y Yamada, et al. 2004 Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis Clin Rheumatol 23 218 222 10.1007/s10067-003-0860-9 15168148 (Pubitemid 38812199)
15. S Kondo T Mashima M Kai Y Yamada M Yoshizawa T Hosoda 1997 The study of serum antiagalactosyl IgG antibody in early rheumatoid arthritis Rinshou Kenkyu 31 190 194
16. JK Lacki W Porawska U Mackiewicz S Mackiewicz W Muller 1996 Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis Ann Med 28 265 269 10.3109/07853899609033129 1:STN:280:DyaK28vgslSrtg%3D%3D 8811171 (Pubitemid 26191065)
17. D van Zeben GA Rook JM Hazes AH Zwinderman Y Zhang S Ghelani, et al. 1994 Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study Br J Rheumatol 33 36 43 10.1093/rheumatology/33.1.36 8162455 (Pubitemid 24042034)
18. MC Lu SC Hsieh NS Lai KJ Li CH Wu CL Yu 2007 Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics Clin Exp Rheumatol 25 716 721 18078619
19. Y Mimra H Ihn M Jinnin Y Asano K Yamane N Yazawa, et al. 2005 Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma Int J Dermatol 44 817 820 10.1111/j.1365-4632.2005.02584.x 16207181 (Pubitemid 41535696)
20. Y Mimura H Ihn M Jinnin Y Asano K Yamane N Yazawa, et al. 2004 Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis Br J Dermatol 151 803 808 10.1111/j.1365-2133.2004.06195.x 1:CAS:528: DC%2BD2cXhtVKitrrO 15491420 (Pubitemid 39482113)
21. C Nishijima S Sato K Takehara 2001 Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis J Rheumatol 28 1847 1851 1:STN:280:DC%2BD3Mvmtlahsw%3D%3D 11508588 (Pubitemid 32726932)
22. M Leirisalo-Repo HE Hernandez-Munoz GA Rook 1999 Agalactosyl IgG is elevated in patients with active spondyloarthropathy Rheumatol Int 18 171 176 10.1007/s002960050080 1:STN:280:DyaK1Mzisl2qsg%3D%3D 10399791 (Pubitemid 29294978)
23. EM Tan AS Cohen JF Fries AT Masi DJ McShane NF Rothfield, et al. 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271 1277 10.1002/art.1780251101 1:STN:280: DyaL3s%2FkvVCmtA%3D%3D 7138600 (Pubitemid 13221242)
24. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 10.1002/art.1780400928 1:STN:280:DyaK2svmsVaisw%3D%3D 9324032
25. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 581 590 10.1002/art.1780230510 (Pubitemid 10101764)
26. E Kudo-Tanaka S Ohshima M Ishii T Mima M Matsushita N Azuma, et al. 2007 Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis Clin Rheumatol 26 1627 1633 10.1007/s10067-007-0558-5 17286215
27. Y Ichikawa C Yamada T Horiki Y Hoshina M Uchiyama Y Yamada, et al. 1998 Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjogren's syndrome and rheumatoid arthritis Clin Exp Rheumatol 16 709 715 1:STN:280:DyaK1M%2FmtVOmtg%3D%3D 9844764 (Pubitemid 28506092)
28. I Ezaki M Shingu E Furuta 1995 Clinical significance of anti-agalactosyl IgG antibody in early rheumatoid arthritis Kiso Rinsho 30 3599 3606
29. N Maeno S Takei S Fujikawa Y Yamada H Imanaka M Hokonohara, et al. 2004 Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjogren's syndrome, and healthy children J Rheumatol 31 1211 1217 1:CAS:528:DC%2BD2cXlsFWgt7k%3D 15170938 (Pubitemid 38715901)
30. MT Chan P Owen J Dunphy B Cox C Carmichael E Korendowych, et al. 2008 Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus J Rheumatol 35 77 83 18085741
31. ER Vossenaar TJ Smeets MC Kraan JM Raats WJ van Venrooij PP Tak 2004 The presence of citrullinated proteins is not specific for rheumatoid synovial tissue Arthritis Rheum 50 3485 3494 10.1002/art.20584 1:CAS:528: DC%2BD2cXhtVOqtrvL 15529392 (Pubitemid 39488673)
32. T Matsui K Shimada S Tohma 2006 Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis Clin Rheumatol 25 610 611 10.1007/s10067-005-0108-y 16283420 (Pubitemid 44137657)